What Sets Us Apart: Board-certified physicians
Front Med (Lausanne) (2022) 9:875430
10 Expanding the use of GLP-1RAs to treat substance use disorders To date, only a limited number of clinical trials have evaluated the effectiveness of GLP-1RAs for substance use disorders, yet initial findings are encouraging
For example, if injecting in the abdomen, you might use the upper right quadrant one week, lower right the next, then lower left, and upper left, before returning to the starting position
Ozempic (semaglutide for type 2 diabetes) comes in multi-dose pens with different strengths: 2 mg/1.5 mL pen (delivers 0.25 mg or 0.5 mg doses) 4 mg/3 mL pen (delivers 1 mg doses) 8 mg/3 mL pen (delivers 2 mg doses) Each pen contains multiple doses and is designed to deliver specific dose increments only
Listen Now: Transcript: This transcript is automatically generated